うつ病のメカニズムと抗うつ作用に関する近年の動物研究の動向

Abela, A. R., Browne, C. J., Sargin, D., Prevot, T. D., Ji, X. D., Li, Z., Lambe, E. K., & Fletcher, P. J. (2020). Median raphe serotonin neurons promote anxiety like behavior via inputs to the dorsal hippocampus. Neuropharmacology, 168, 107985. https://doi.org/10.1016/j.neuropharm.2020.107985

Acher, F. C. (2011). Metabotropic Glutamate Receptors. Tocris Bioscience Scientific Review Series, 26, 1-20.

Aizawa, H., Amo, R., & Okamoto, H. (2011). Phylogeny and ontogeny of the habenular structure. Frontiers in Neuroscience, 5, 138. https://doi.org/10.3389/fnins.2011.00138

Aldosary, F., Norris, S., Tremblay, P., James, J. S., Ritchie, J. C., & Blier, P. (2022). Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder. International Journal of Neuropsychopharmacology, 25(4), 283–292. https://doi.org/10.1093/ijnp/pyab086

Amat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., & Maier, S. F. (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neuroscience, 8(3), 365-71. https://doi.org/10.1038/nn1399

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed., pp. 160–179). American Psychiatric Publishing.

Anttila, S. A., & Leinonen, E. V. (2001). A review of the pharmacological and clinical profile of mirtazapine. CNS drug reviews, 7(3), 249–264. https://doi.org/10.1111/j.1527-3458.2001.tb00198.x

Arosio, B., Guerini, F. R., Oude Voshaar, R. C., & Aprahamian, I. (2021). Blood brain derived neurotrophic factor (BDNF) and major depression: Do we have a translational perspective? Frontiers in Behavioral Neuroscience, 15, 626906. https://doi.org/10.3389/fnbeh.2021.626906

Austelle, C. W., O’Leary, G. H., Thompson, S., Gruber, E., Kahn, A., Manett, A. J., Short, B., & Badran, B. W. (2022). A Comprehensive Review of Vagus Nerve Stimulation for Depression. Neuromodulation, 25(3), 309–315. https://doi.org/10.1111/ner.13528

Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P. F., Kavalali, E. T., & Monteggia, L. M. (2011). NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature, 475(7354), 91–95. https://doi.org/10.1038/nature10130

Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., Rau, H., Hoff, H. J., Padberg, F., Müller-Siecheneder, F., Audenaert, K., van den Abbeele, D., Matthews, K., Christmas, D., Eljamel, S., & Heuser, I. (2010). Two-year outcome of vagus nerve stimulation in treatment-resistant depression. Journal of Clinical Psychopharmacology, 30(3), 273–281. https://doi.org/10.1097/JCP.0b013e3181db8831

Banks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., Meabon, J. S., Wing, E. E., Morofuji, Y., Cook, D. G., & Reed, M. J. (2015). Lipopolysaccharide-induced blood-brain barrier disruption: Roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. Journal of Neuroinflammation, 12, 223. https://doi.org/10.1186/s12974-015-0434-1

Bauer, M., Tharmanathan, P., Volz, H. P., Moeller, H. J., & Freemantle, N. (2009). The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 259(3), 172–185. https://doi.org/10.1007/s00406-008-0849-0

Belujon, P., & Grace, A. A. (2017). Dopamine system dysregulation in major depressive disorders. International Journal of Neuropsychopharmacology, 20(12), 1036–1046. https://doi.org/10.1093/ijnp/pyx056

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351-354. https://doi.org/10.1016/S0006-3223(99)00230-9

Berthoux, C., Marin, P., Felder-Schmittbuhl, M.-P., Bécamel, C., & Marin, P. (2018). Sustained activation of postsynaptic 5 HT₂A receptors gates plasticity at prefrontal cortex synapses. Cerebral Cortex, 29(4), 1659–1669. https://doi.org/10.1093/cercor/bhy064

Beurel, E., Song, L., & Jope, R. S. (2011). Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Molecular Psychiatry, 16(11), 1068–1070. https://doi.org/10.1038/mp.2011.47

Birkinshaw, H., Friedrich, C., Cole, P., Eccleston, C., Serfaty, M., Stewart, G., White, S., Moore, A., Phillippo, D., & Pincus, T. (2024). Antidepressants for pain management in adults with chronic pain: A network meta-analysis. Health Technology Assessment, 28(62), 1–155. https://doi.org/10.3310/MKRT2948

Blier, P., & de Montigny, C. (1994). Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences, 15(7), 220–226. https://doi.org/10.1016/0165-6147(94)90315-8

Bobkova, N. V., Chuvakova, L. N., Kovalev, V. I., Zhdanova, D. Y., Chaplygina, A. V., Rezvykh, A. P., & Evgen'ev, M. B. (2025). A Mouse Model of Sporadic Alzheimer's Disease with Elements of Major Depression. Molecular neurobiology, 62(2), 1337–1358. https://doi.org/10.1007/s12035-024-04346-7

Boulton, A. A., Baker, G. B., & Greenshaw, A. J. (Eds.) (2018). Hallucinogens, PCP, and Ketamine. In Psychopharmacology (3rd ed., pp.500-515). Humana Press.

Brodkin, J., Bradbury, M., Busse, C., Warren, N., Bristow, L. J., & Varney, M. A. (2002). Reduced stress-induced hyperthermia in mGluR5 knockout mice. European Journal of Neuroscience, 16(12), 2301–2307. https://doi.org/10.1046/j.1460-9568.2002.02294.x

Bymaster, F. P., Lee, T. C., Knadler, M. P., Detke, M. J., & Iyengar, S. (2005). The dual transporter inhibitor duloxetine: A review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Current Pharmaceutical Design, 11(12), 1475–1493. https://doi.org/10.2174/1381612053764805

Cahn, C. (2006). Roland Kuhn, 1912–2005. Neuropsychopharmacology, 31(5), 1096. https://doi.org/10.1038/sj.npp.1301026

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Pilling, S., Curran, V. H., & Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. Lancet Psychiatry, 3(7), 619–627. https://doi.org/10.1016/S2215-0366(16)30065-7

Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., & Nutt, D. J. (2018). Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up. Psychopharmacology, 235(2), 399–408. https://doi.org/10.1007/s00213-017-4771-x.

Caldecott-Hazard, S., Mazziotta, J., & Phelps, M. (1988). Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. The Journal of neuroscience : the official journal of the Society for Neuroscience, 8(6), 1951–1961. https://doi.org/10.1523/JNEUROSCI.08-06-01951.1988

Carlsson, A. (2018, July 1). Arvid Carlsson. Sahlgrenska Academy. Retrieved December 6, 2024, from https://web.archive.org/web/20180701030548/https://sahlgrenska.gu.se/english/research/researchers/arvid-carlsson

Carlsson, A., Corrodi, H., Fuxe, K., & Hökfelt, T. (1969). Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. European Journal of Pharmacology, 5(4), 357–366. https://doi.org/10.1016/0014-2999(69)90113-7

Carregosa, D., Loncarevic-Vasiljkovic, N., Feliciano, R., Moura-Louro, D., Mendes, C. S., & Dos Santos, C. N. (2024). Locomotor and gait changes in the LPS model of neuroinflammation are correlated with inflammatory cytokines in blood and brain. Journal of Inflammation, 21(1), 39. https://doi.org/10.1186/s12950-024-00412-y

CenterWatch. (2025, October 2). Investigation of the antidepressant effects of (2R,6R)-HNK, an enhancer of synaptic glutamate release, in treatment-resistant depression (Clinical trial NCT06511908). https://www.centerwatch.com/clinical-trials/listings/NCT06511908/investigation-of-the-antidepressant-effects-of-2r6r-hnk-an-enhancer-of-synaptic-glutamate-release-in-treatment-resistant-depression

Chaki, S., & Watanabe, M. (2023). mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development. European Archives of Psychiatry and Clinical Neuroscience, 273(7), 1451–1462. https://doi.org/10.1007/s00406-023-01561-6

Chekroud, A. M., Zotti, R. J., Shehzad, Z., Gueorguieva, R., Johnson, M. K., Trivedi, M. H., Cannon, T. D., Krystal, J. H., & Corlett, P. R. (2016). Cross-trial prediction of treatment outcome in depression: a machine learning approach. The Lancet. Psychiatry, 3(3), 243–250. https://doi.org/10.1016/S2215-0366(15)00471-X

Chen, X., Liu, X., Luan, S., Liu, Y., Song, D., Zhang, H., Sun, Y., Wang, T., Liu, X., & Yan, J. (2024). Optogenetic activation of the lateral habenula D1R–ventral tegmental area circuit induces depression-like behavior in mice. European Archives of Psychiatry and Clinical Neuroscience, 274(6), 867–878. https://doi.org/10.1007/s00406-023-01743-2

Chessin, M., Kramer, E. R., & Scott, C. C. (1957). Modifications of the pharmacology of reserpine and serotonin by iproniazid. The Journal of Pharmacology and Experimental Therapeutics, 119(4), 453 460.

Chinta, S. J., & Andersen, J. K. (2005). Dopaminergic neurons. The International Journal of Biochemistry & Cell Biology, 37(5), 942–946. https://doi.org/10.1016/j.biocel.2004.12.011

Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA, 309(16), 1696–1703. https://doi.org/10.1001/jama.2013.2270

Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7

Cohen, J. Y., Amoroso, M. W., & Uchida, N. (2015). Serotonergic neurons signal reward and punishment on multiple timescales. eLife, 4, e06346. https://doi.org/10.7554/eLife.06346

Cole, A. B., Montgomery, K., Bale, T. L., & Thompson, S. M. (2022). What the hippocampus tells the HPA axis: Hippocampal output attenuates acute stress responses via disynaptic inhibition of CRF+ PVN neurons. Neurobiology of Stress, 20, 100473. https://doi.org/10.1016/j.ynstr.2022.100473

Commons, K. G., & Linnros, S. E. (2019). Delayed antidepressant efficacy and the desensitization hypothesis. ACS Chemical Neuroscience, 10(7), 3048–3052. https://doi.org/10.1021/acschemneuro.8b00698

Conway, C. R., Aaronson, S. T., Sackeim, H. A., George, M. S., Zajecka, J., Bunker, M. T., Duffy, W., Stedman, M., Riva Posse, P., Allen, R. M., Quevedo, J., Berger, M., Alva, G., Malik, M. A., Dunner, D. L., Cichowicz, I., Banov, M., Manu, L., Nahas, Z., Macaluso, M., Mickey, B. J., Sheline, Y., Kriedt, C. L., Lee, Y. C., Gordon, C., Shy, O., Tran, Q., Yates, L., & Rush, A. J. (2025 May Jun). Vagus nerve stimulation in treatment resistant depression: A one year, randomized, sham controlled trial. Brain Stimulation, 18(3), 676 689. https://doi.org/10.1016/j.brs.2024.12.1191

Cools, R., Roberts, A. C., & Robbins, T. W. (2008). Serotoninergic regulation of emotional and behavioural control processes. Trends in Cognitive Sciences, 12(1), 31-40. https://doi.org/10.1016/j.tics.2007.10.011

Cording, M., Derry, S., Phillips, T., Moore, R. A., & Wiffen, P. J. (2015). Milnacipran for pain in fibromyalgia in adults. Cochrane Database of Systematic Reviews, 10, CD008244. https://doi.org/10.1002/14651858.CD008244.pub3

Cosci, F., & Chouinard, G. (2019). The monoamine hypothesis of depression revisited: Could it mechanistically novel antidepressant strategies? In J. Quevedo, A. F. Carvalho, & C. A. Zarate (Eds.), Neurobiology of Depression (pp. 63–73). Academic Press. https://doi.org/10.1016/B978-0-12-813333-0.00007-X

Cui, Y., Yang, Y., Ni, Z., Dong, Y., Cai, G., Foncelle, A., Ma, S., Hu, H., & Li, B. (2018). Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression. Nature, 554(7692), 323–327. https://doi.org/10.1038/nature25752

Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 78(5), 481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285

de Freitas, C. M., Busanello, A., Schaffer, L. F., Peroza, L. R., Krum, B. N., Leal, C. Q., Ceretta, A. P., da Rocha, J. B., & Fachinetto, R. (2016). Behavioral and neurochemical effects induced by reserpine in mice. Psychopharmacology, 233(3), 457–467. https://doi.org/10.1007/s00213-015-4118-4

de Souza, F. S., & Franci, C. R. (2008). GABAergic mediation of stress-induced secretion of corticosterone and oxytocin, but not prolactin, by the hypothalamic paraventricular nucleus. Life Sciences, 83(21 22), 768–774. https://doi.org/10.1016/j.lfs.2008.09.007

Donahue, R. J., Muschamp, J. W., Russo, S. J., Nestler, E. J., & Carlezon, W. A., Jr (2014). Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice. Biological Psychiatry, 76(7), 550–558. https://doi.org/10.1016/j.biopsych.2013.12.014

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67(5), 446-457. https://doi.org/10.1016/j.biopsych.2009.09.033

Duman, R. S., & Monteggia, L. M. (2006). A neurotrophic model for stress related mood disorders. Biological Psychiatry, 59(12), 1116–1127. https://doi.org/10.1016/j.biopsych.2006.02.013

Duman, R. S., Heninger, G. R., & Nestler, E. J. (1997). A molecular and cellular theory of depression. Archives of General Psychiatry, 54(7), 597–606. https://doi.org/10.1001/archpsyc.1997.01830190015002

Dwyer, J. M., Lepack, A. E., & Duman, R. S. (2012). mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade. The International Journal of Neuropsychopharmacology, 15(4), 429–434. https://doi.org/10.1017/S1461145711001702

Farina de Almeida, R., Ganzella, M., Machado, D. G., Loureiro, S. O., Leffa, D., Quincozes-Santos, A., Pettenuzzo, L. F., Frescura Duarte, M. M. M., Duarte, T., & Souza, D. O. (2017). Olfactory bulbectomy in mice triggers transient and long-lasting behavioral impairments and biochemical hippocampal disturbances. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 76, 1–11. https://doi.org/10.1016/j.pnpbp.2017.02.003

Feyissa, A. M., Woolverton, W. L., Miguel Hidalgo, J. J., Wang, Z., Kyle, P. B., Hasler, G., Stockmeier, C. A., Iyo, A. H., & Karolewicz, B. (2010). Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(2), 279–283. https://doi.org/10.1016/j.pnpbp.2009.11.018

Fogaça, M. V., & Duman, R. S. (2019). Cortical GABAergic dysfunction in stress and depression: New insights for therapeutic interventions. Frontiers in Cellular Neuroscience, 13, 87. https://doi.org/10.3389/fncel.2019.00087

Fonseca, M. S., Murakami, M., & Mainen, Z. F. (2015). Activation of dorsal raphe serotonergic neurons promotes waiting but is not reinforcing. Current Biology, 25(3), 306–315. https://doi.org/10.1016/j.cub.2014.12.002

Fortin, J. S., Lafleur, M., Parisien, C., & Hétu, S. (2025). The habenula in mood disorders: A systematic review of human studies. Molecular Psychiatry, 2025 Oct;30(10):4948-4970. https://doi.org/10.1038/s41380-025-03105-x

Franco, R., Reyes Resina, I., & Navarro, G. (2021). Dopamine in health and disease: Much more than a neurotransmitter. Biomedicines, 9(2), 109. https://doi.org/10.3390/biomedicines9020109

Freis, E. D. (1954). Mental depression in hypertensive patients treated for long periods with large doses of reserpine. The New England Journal of Medicine, 251(25), 1006–1008. https://doi.org/10.1056/NEJM195412162512504

Fries, G. R., Saldana, V. A., & Finnstein, J. (2023). Molecular pathways of major depressive disorder converge on the synapse. Molecular Psychiatry, 28(1), 284–297. https://doi.org/10.1038/s41380-022-01806-1

Frisbee, J. C., Brooks, S. D., Stanley, S. C., & d'Audiffret, A. C. (2015). An unpredictable chronic mild stress protocol for instigating depressive symptoms, behavioral changes, and negative health outcomes in rodents. Journal of Visualized Experiments, 106, https://doi.org/10.3791/53109

Fritze, S., Spanagel, R., & Noori, H. R. (2017). Adaptive dynamics of the 5-HT systems following chronic administration of selective serotonin reuptake inhibitors: A meta-analysis. Journal of Neurochemistry, 142(5), 747–755. https://doi.org/10.1111/jnc.14114

Gazdag, G., Bitter, I., Ungvari, G. S., & Baran, B. (2009). Convulsive therapy turns 75. British Journal of Psychiatry, 194(5), 387-388. https://doi.org/10.1192/bjp.bp.108.062547

Gao, Z. Y., Yang, P., Huang, Q. J., & Xu, H. Y. (2016). The influence of dizocilpine on the reserpine-induced behavioral and neurobiological changes in rats. Neuroscience Letters, 614, 89–94. https://doi.org/10.1016/j.neulet.2016.01.006

Geyer, M. A., Wilkinson, L. S., Humby, T., & Robbins, T. W. (1993). Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biological Psychiatry, 34(6), 361–372. https://doi.org/10.1016/0006-3223(93)90180-l

Gilles, Y. D., & Polston, E. K. (2017). Effects of social deprivation on social and depressive-like behaviors and the numbers of oxytocin expressing neurons in rats. Behavioural Brain Research, 328, 28–38. https://doi.org/10.1016/j.bbr.2017.03.036

Guo, J., Lin, P., Zhao, X., Zhang, J., Wei, X., Wang, Q., & Wang, C. (2014). Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response, and depressive-like behavior in mice. Neuroscience, 263, 1-14. https://doi.org/10.1016/j.neuroscience.2014.01.008

Glassman, A. H., & Bigger, J. T. Jr. (1981). Cardiovascular effects of therapeutic doses of tricyclic antidepressants: A review. Archives of General Psychiatry, 38(7), 815–820. https://doi.org/10.1001/archpsyc.1981.01780320095011

Gray, N. A., Milak, M. S., DeLorenzo, C., Ogden, R. T., Huang, Y. Y., Mann, J. J., & Parsey, R. V. (2013). Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. Biological Psychiatry, 74(1), 26–31. https://doi.org/10.1016/j.biopsych.2012.11.012

Golden, S. A., Covington, H. E., 3rd, Berton, O., & Russo, S. J. (2011). A standardized protocol for repeated social defeat stress in mice. Nature Protocols, 6(8), 1183–1191. https://doi.org/10.1038/nprot.2011.361

Han, X., Wang, W., Shao, F., & Li, N. (2011). Isolation rearing alters social behaviors and monoamine neurotransmission in the medial prefrontal cortex and nucleus accumbens of adult rats. Brain Research, 1385, 175–181. https://doi.org/10.1016/j.brainres.2011.02.035

Hao, Y., Ge, H., Sun, M., & Gao, Y. (2019). Selecting an appropriate animal model of depression. International Journal of Molecular Sciences, 20(19), 4827. https://doi.org/10.3390/ijms20194827

Hashimoto, K., Sawa, A., & Iyo, M. (2007). Increased levels of glutamate in brains from patients with mood disorders. Biological Psychiatry, 62(11), 1310–1316. https://doi.org/10.1016/j.biopsych.2007.03.017

Hassanein, E. H. M., Althagafy, H. S., Baraka, M. A., Abd alhameed, E. K., & Ibrahim, I. M. (2023). Pharmacological update of mirtazapine: a narrative literature review. Naunyn Schmiedeberg’s Archives of Pharmacology, 397(5), 2603 2619. https://doi.org/10.1007/s00210-023-02818-6

Hatch, A. M., Wiberg, G. S., Zawidzka, Z., Cann, M., Airth, J. M., & Grice, H. C. (1965). Isolation syndrome in the rat. Toxicology and Applied Pharmacology, 7(5), 737–745. https://doi.org/10.1016/0041-008X(65)90132-8

Hayashi, K., Nakao, K., & Nakamura, K. (2015). Appetitive and aversive information coding in the primate dorsal raphé nucleus. The Journal of Neuroscience : the official journal of the Society for Neuroscience, 35(15), 6195–6208. https://doi.org/10.1523/JNEUROSCI.2860-14.2015

Healy, D. (2000). Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression. James Lorimer & Company.

Hellweg, R., Zueger, M., Fink, K., Hörtnagl, H., & Gass, P. (2007). Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiology of Disease, 25(1), 1–7. https://doi.org/10.1016/j.nbd.2006.08.006

Herkenham, M., & Nauta, W. J. H. (1979). Efferent connections of the habenular nuclei in the rat. The Journal of Comparative Neurology, 187(1), 19–47. https://doi.org/10.1002/cne.901870103

Hermes, G., Li, N., Duman, C., & Duman, R. S. (2011). Post-weaning chronic social isolation produces profound behavioral dysregulation with decreases in prefrontal cortex synaptic-associated protein expression in female rats. Physiology & Behavior, 104(2), 354–359. https://doi.org/10.1016/j.physbeh.2010.12.019

Hikosaka, O. (2010). The habenula: from stress evasion to value-based decision-making. Nature Reviews Neuroscience, 11, 503–513. https://doi.org/10.1038/nrn2866

Hu, H., Cui, Y. & Yang, Y. (2020). Circuits and functions of the lateral habenula in health and in disease. Nature Reviews Neuroscience, 21, 277–295. https://doi.org/10.1038/s41583-020-0292-4

Huang, K. W., Ochandarena, N. E., Philson, A. C., Hyun, M., Birnbaum, J. E., Cicconet, M., & Sabatini, B. L. (2019). Molecular and anatomical organization of the dorsal raphe nucleus. eLife, 8, e46464. https://doi.org/10.7554/eLife.46464

Huys, Q., Maia, T. & Frank, M. Computational psychiatry as a bridge from neuroscience to clinical applications. Nature Neuroscience, 19, 404–413 (2016). https://doi.org/10.1038/nn.4238

Inaba, K., Mizuhiki, T., Setogawa, T., Toda, K., Richmond, B. J., & Shidara, M. (2013). Neurons in monkey dorsal raphe nucleus code beginning and progress of step-by-step schedule, reward expectation, and amount of reward outcome in the reward schedule task. The Journal of neuroscience : the official journal of the Society for Neuroscience, 33(8), 3477–3491. https://doi.org/10.1523/JNEUROSCI.4388-12.2013

Ishikawa, H., Kawakami, N., Kessler, R. C., & World Mental Health Japan Survey Collaborators (2016). Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: Results from the final dataset of World Mental Health Japan Survey. Epidemiology and Psychiatric Sciences, 25(3), 217–229. https://doi.org/10.1017/S2045796015000566

Jauhar, S., Arnone, D., Baldwin, D. S., Goodwin, G. M., Geddes, J. R., & Young, A. H. (2023). A leaky umbrella has little value: Evidence clearly indicates the serotonin system is implicated in depression. Molecular Psychiatry, 28(9), 3149–3152. https://doi.org/10.1038/s41380-023-02095-y

Jiang, Y., Zou, M., Ren, T., & Wang, Y. (2023). Are mGluR2/3 Inhibitors Potential Compounds for Novel Antidepressants? Cellular and Molecular Neurobiology, 43, 1931–1940. https://doi.org/10.1007/s10571-022-01310-8

Jin, H., Li, M., Jeong, E., Castro Martinez, F., & Zuker, C. S. (2024). A body–brain circuit that regulates body inflammatory responses. Nature, 630(8017), 695–703. https://doi.org/10.1038/s41586-024-07469-y

Joffe, M. E., Santiago, C. I., Oliver, K. H., Maksymetz, J., Harris, N. A., Engers, J. L., Lindsley, C. W., Winder, D. G., & Conn, P. J. (2020). mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects. Neuron, 105(1), 46-59. https://doi.org/10.1016/j.neuron.2019.09.044

Johnson, S. A., Fournier, N. M., & Kalynchuk, L. E. (2006). Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behavioural Brain Research, 168(2), 280–288. https://doi.org/10.1016/j.bbr.2005.11.019

Jones K. (2000). Insulin coma therapy in schizophrenia. Journal of the Royal Society of Medicine, 93(3), 147-149. https://doi.org/10.1177/014107680009300313

Jourdi, H., Hsu, Y. T., Zhou, M., Qin, Q., Bi, X., & Baudry, M. (2009). Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation. The Journal of Neuroscience : the official journal of the Society for Neuroscience, 29(27), 8688–8697. https://doi.org/10.1523/JNEUROSCI.6078-08.2009

Kamp, C. B., Petersen, J. J., Faltermeier, P., Juul, S., Siddiqui, F., Barbateskovic, M., Kristensen, A. T., Moncrieff, J., Horowitz, M. A., Hengartner, M. P., Kirsch, I., Gluud, C., & Jakobsen, J. C. (2024). Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: A systematic review with meta-analysis and trial sequential analysis. BMJ Mental Health, 27(1), e300730. https://doi.org/10.1136/bmjment-2023-300730

Kavalali, E. T., & Monteggia, L. M. (2025). Synaptic basis of rapid antidepressant action. European archives of psychiatry and clinical neuroscience, 275(6), 1539–1546. https://doi.org/10.1007/s00406-024-01898-6

Kawai, H., Bouchekioua, Y., Nishitani, N., Niitani, K., Izumi, S., Morishita, H., Andoh, C., Nagai, Y., Koda, M., Hagiwara, M., Toda, K., Shirakawa, H., Nagayasu, K., Ohmura, Y., Kondo, M., Kaneda, K., Yoshioka, M., & Kaneko, S. (2022). Median raphe serotonergic neurons projecting to the interpeduncular nucleus control preference and aversion. Nature Communications, 13, 7708. https://doi.org/10.1038/s41467-022-35346-7

Kellner, C. H., Rubinow, D. R., & Post, R. M. (1986). Cerebral ventricular size and cognitive impairment in depression. Journal of Affective Disorders, 10(3), 215–219. https://doi.org/10.1016/0165-0327(86)90007-8

Kielholz, P. (1968). Diagnose und Therapie der Depressionen für den Praktiker (pp. 82–87). Bern, Switzerland: Hans Huber.

King, M. G., & Cairncross, K. D. (1974). Effects of olfactory bulb section on brain noradrenaline, corticosterone and conditioning in the rat. Pharmacology Biochemistry and Behavior, 2(3), 347–353. https://doi.org/10.1016/0091-3057(74)90079-3

Kinlein, S. A., Wilson, C. D., & Karatsoreos, I. N. (2015). Dysregulated hypothalamic–pituitary–adrenal axis function contributes to altered endocrine and neurobehavioral responses to acute stress. Frontiers in Psychiatry, 6, 31. https://doi.org/10.3389/fpsyt.2015.00031

Kline, N.S., & Cooper, T.B. (1980). Monoamine Oxidase Inhibitors as Antidepressants. In: Hoffmeister, F., Stille, G. (eds) Psychotropic Agents. Handbook of Experimental Pharmacology, vol 55 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67538-6_17

Koike, H., & Chaki, S. (2014). Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats. Behavioural Brain Research, 271, 111–115. https://doi.org/10.1016/j.bbr.2014.05.065

Koike, H., Fukumoto, K., Iijima, M., & Chaki, S. (2013). Role of BDNF/TrkB signaling in antidepressant like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression. Behavioural Brain Research, 238, 48–52. https://doi.org/10.1016/j.bbr.2012.10.023

Kryst, J., Kawalec, P., Mitoraj, A. M., Pilc, A., Lasoń, W., & Brzostek, T. (2020). Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: A meta-analysis of randomized clinical trials. Pharmacological Reports, 72, 543–562. https://doi.org/10.1007/s43440-020-00097-z

Krystal, J. H., Kavalali, E. T., & Monteggia, L. M. (2024). Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 49(1), 41–50. https://doi.org/10.1038/s41386-023-01629-w

Lanquillon, S., Krieg, J. C., Bening-Abu-Shach, U., & Vedder, H. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology, 22(4), 370-379. https://doi.org/10.1016/S0893-133X(99)00134-7

Lecca, S., Pelosi, A., Tchenio, A., Moutkine, I., Luján, R., Hervé, D., & Mameli, M. (2016). Rescue of GABA₍B₎ and GIRK function in the lateral habenula by protein phosphatase 2A inhibition ameliorates depression-like phenotypes in mice. Nature Medicine, 22(3), 254–261. https://doi.org/10.1038/nm.4037

Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015). BDNF release is required for the behavioral actions of ketamine. International Journal of Neuropsychopharmacology, 18(1). https://doi.org/10.1093/ijnp/pyu033

Li, L., & Vlisides, P. E. (2016). Ketamine: 50 years of modulating the mind. Frontiers in Human Neuroscience, 10, 612. https://doi.org/10.3389/fnhum.2016.00612

Li, R., Zhao, D., Qu, R., Fu, Q., & Ma, S. (2015). The effects of apigenin on lipopolysaccharide-induced depressive-like behavior in mice. Neuroscience Letters, 594, 17-22. https://doi.org/10.1016/j.neulet.2015.03.040

Liu, R. J., Fuchikami, M., Dwyer, J. M., Lepack, A. E., Duman, R. S., & Aghajanian, G. K. (2013). GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 38(11), 2268–2277. https://doi.org/10.1038/npp.2013.128

Li, Y., Zhong, W., Wang, D., Feng, Q., Liu, Z., Zhou, J., Jia, C., Hu, F., Zeng, J., Guo, Q., Fu, L., & Luo, M. (2016). Serotonin neurons in the dorsal raphe nucleus encode reward signals. Nature Communications, 7, 10503. https://doi.org/10.1038/ncomms10503

Li, W., Ali, T., He, K., Liu, Z., Shah, F. A., Ren, Q., Liu, Y., Jiang, A., & Li, S. (2021). Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression. Brain, Behavior, and Immunity, 92, 10-24. https://doi.org/10.1016/j.bbi.2020.11.008

Liu, B., Cao, Y., Wang, J., & Dong, J. (2020). Excitatory transmission from ventral pallidum to lateral habenula mediates depression. The World Journal of Biological Psychiatry, 21(8), 627–633. https://doi.org/10.1080/15622975.2020.1725117

Liu, R. J., Fuchikami, M., Dwyer, J. M., Lepack, A. E., Duman, R. S., & Aghajanian, G. K. (2013). GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 38(11), 2268–2277. https://doi.org/10.1038/npp.2013.128

López-Giménez, J. F., & González-Maeso, J. (2018). Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways. Current Topics in Behavioral Neurosciences, 36, 45–73. https://doi.org/10.1007/7854_2017_478

López-Muñoz, F., & Alamo, C. (2009). Monoaminergic neurotransmission: the history of the discovery of antidepressants f rom 1950s until today. Current Pharmaceutical Design, 15(14), 1563-86. https://doi.org/10.2174/138161209788168001

Lottem, E., Banerjee, D., Vertechi, P., Sarra, D., Lohuis, M. O., & Mainen, Z. F. (2018). Activation of serotonin neurons promotes active persistence in a probabilistic foraging task. Nature Communications, 9(1), 1000. https://doi.org/10.1038/s41467-018-03438-y

Lowry, C. A., Hale, M. W., Evans, A. K., Heerkens, J., Staub, D. R., Gasser, P. J., & Shekhar, A. (2008). Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Annals of the New York Academy of Sciences, 1148, 86-94. https://doi.org/10.1196/annals.1410.004

Lumsden, E. W., Troppoli, T. A., Myers, S. J., Zanos, P., Aracava, Y., Kehr, J., Lovett, J., Kim, S., Wang, F. H., Schmidt, S., Jenne, C. E., Yuan, P., Morris, P. J., Thomas, C. J., Zarate, C. A. Jr., Moaddel, R., Traynelis, S. F., Pereira, E. F. R., Thompson, S. M., Albuquerque, E. X., & Gould, T. D. (2019). Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America, 116(11), 5160–5169. https://doi.org/10.1073/pnas.1816071116

Luo, M., Zhou, J., & Liu, Z. (2015). Reward processing by the dorsal raphe nucleus: 5-HT and beyond. Learning & Memory, 22(9), 452–460. https://doi.org/10.1101/lm.037317.114

Luo, Y., Cao, Z., Wang, D., Wu, L., Li, Y., Sun, W., & Zhu, Y. (2014). Dynamic study of the hippocampal volume by structural MRI in a rat model of depression. Neurological Sciences, 35, 1777–1783. https://doi.org/10.1007/s10072-014-1837-y

Lv, H., Zhao, Y., Chen, J., Wang, D., & Chen, H. (2019). Vagus nerve stimulation for depression: A systematic review. Frontiers in Psychology, 10, 64. https://doi.org/10.3389/fpsyg.2019.00064

Ma, X. C., Dang, Y. H., Jia, M., Ma, R., Wang, F., Wu, J., Gao, C. G., & Hashimoto, K. (2013). Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice. PLoS ONE, 8(2), e56053. https://doi.org/10.1371/journal.pone.0056053

Machado, M., & Einarson, T. R. (2010). Comparison of SSRIs and SNRIs in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials. Journal of Clinical Pharmacy & Therapeutics, 35(2), 177–188. https://doi.org/10.1111/j.1365-2710.2009.01050.x

Madsen, C. A., Navarro, M. L., Elfving, B., Kessing, L. V., Castrén, E., Mikkelsen, J. D., & Knudsen, G. M. (2024). The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood. European Neuropsychopharmacology, 87, 35–55. https://doi.org/10.1016/j.euroneuro.2024.06.008

Mahfouz, A., Lelieveldt, B. P. F., Grefhorst, A., van Weert, L. T. C. M., Mol, I. M., Sips, H. C. M., van den Heuvel, J. K., Datson, N. A., Visser, J. A., Reinders, M. J. T., & Meijer, O. C. (2016). Genome-wide coexpression of steroid receptors in the mouse brain: Identifying signaling pathways and functionally coordinated regions. Proceedings of the National Academy of Sciences, 113(10), 2738–2743. https://doi.org/10.1073/pnas.1520376113

Mahlich, J., Tsukazawa, S., & Wiegand, F. (2018). Estimating prevalence and healthcare utilization for treatment-resistant depression in Japan: A retrospective claims database study. Drugs—Real World Outcomes, 5(1), 35–43. https://doi.org/10.1007/s40801-017-0126-5

Maier, S. F., & Watkins, L. R. (2005). Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neuroscience Biobehavioral Review, 29(4-5), 829-841. https://doi.org/10.1016/j.neubiorev.2005.03.021

Mao, L. M., Mathur, N., Mahmood, T., Rajan, S., Chu, X. P., & Wang, J. Q. (2022). Phosphorylation and regulation of group II metabotropic glutamate receptors (mGlu2/3) in neurons. Frontiers in Cell and Developmental Biology, 10, 1022544. https://doi.org/10.3389/fcell.2022.1022544

Martin, A. L., & Brown, R. E. (2010). The lonely mouse: verification of a separation-induced model of depression in female mice. Behavioural Brain Research, 207(1), 196–207. https://doi.org/10.1016/j.bbr.2009.10.006

Matsushima, Y., Eguchi, F., Kikukawa, T., & Matsuda, T. (2009). Historical overview of psychoactive mushrooms. Inflammation & Regeneration, 29(1), 47–58. https://doi.org/10.2492/inflammregen.29.47

松下 正明・昼田 源四郎. (1999). 精神医療の歴史. 中山書店.

Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M. A., Baker, G. B., & Dursun, S. M. (2020). Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers. Therapeutic Advances in Psychopharmacology, 10, https://doi.org/10.1177/2045125320916657

Meyer, J. S., Farrar, A. M., Biezonski, D., & Yates, J. R. (2022). Psychopharmacology: Drugs, the brain, and behavior (4th ed.). Sinauer Associates (Oxford University Press).

Meyer, J. S., & Quenzer, L. F. (2018). Psychopharmacology: Drugs, the brain, and behavior (3rd ed.). Oxford University Press.

Miller, O. H., Yang, L., Wang, C. C., Hargroder, E. A., Zhang, Y., Delpire, E., & Hall, B. J. (2014). GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine. eLife, 3, e03581. https://doi.org/10.7554/eLife.03581

Miyazaki, K. W., Miyazaki, K., Tanaka, K. F., Yamanaka, A., Takahashi, A., Tabuchi, S., & Doya, K. (2014). Optogenetic activation of dorsal raphe serotonin neurons enhances patience for future rewards. Current Biology, 24(17), 2033–2040. https://doi.org/10.1016/j.cub.2014.07.041

Moghaddam, B., Bolinao, M. L., Stein-Behrens, B., & Sapolsky, R. (1994). Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Research, 655(1–2), 251–254. https://doi.org/10.1016/0006-8993(94)91622-5

Molloy, B. B. (1999). Inductee details. The National Inventors Hall of Fame. Retrieved December 6, 2024, from https://www.invent.org/inductees/bryan-b-molloy

Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28(9), 3243–3256. https://doi.org/10.1038/s41380-022-01661-0

Morales-Medina, J. C., Iannitti, T., Freeman, A., & Caldwell, H. K. (2017). The olfactory bulbectomized rat as a model of depression: The hippocampal pathway. Behavioural Brain Research, 317, 562–575. https://doi.org/10.1016/j.bbr.2016.09.029

Moriguchi, S., Yamada, M., Takano, H., Nagashima, T., Takahata, K., Yokokawa, K., Ito, T., Ishii, T., Kimura, Y., Zhang, M.-R., Mimura, M., & Suhara, T. (2016). Norepinephrine transporter in major depressive disorder: A PET study. American Journal of Psychiatry, 174(1), 36–41. https://doi.org/10.1176/appi.ajp.2016.15101334

MSD Manuals. (n.d.). Depression: Treatment. MSD Manuals. Retrieved November 5, 2025, from https://www.merckmanuals.com/home/mental-health-issues/mood-disorders/depression-treatment

Muir, J., Lin, S., Aarrestad, I.K., Daniels, H.R., Ma, J., Tian, L., Olson, D.E., & Kim, C.K. (2024). Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states. Science, 386, 802–810. https://doi.org/10.1126/science.adl0666

Naert, G., Maurice, T., Tapia-Arancibia, L., & Givalois, L. (2007). Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats. Psychoneuroendocrinology, 32(8-10), 1062–1078. https://doi.org/10.1016/j.psyneuen.2007.09.002

Nakamura, K., Matsumoto, M., & Hikosaka, O. (2008). Reward-dependent modulation of neuronal activity in the primate dorsal raphe nucleus. The Journal of neuroscience : the official journal of the Society for Neuroscience, 28(20), 5331–5343. https://doi.org/10.1523/JNEUROSCI.0021-08.2008

Nestler, E. J., & Russo, S. J. (2024). Neurobiological basis of stress resilience. Neuron, 112(12), 1911–1929. https://doi.org/10.1016/j.neuron.2024.05.001

Nibuya, M., Morinobu, S., & Duman, R. S. (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. The Journal of Neuroscience : the official journal of the Society for Neuroscience, 15(11), 7539–7547. https://doi.org/10.1523/JNEUROSCI.15-11-07539.1995

野村 総一郎. (2008). うつ病の真実. 日本評論社

Nowak, G., Pomierny-Chamioło, L., Siwek, A., Niedzielska, E., Pomierny, B., Pałucha-Poniewiera, A., & Pilc, A. (2014). Prolonged administration of antidepressant drugs leads to increased binding of [3H]MPEP to mGlu5 receptors. Neuropharmacology, 84, 46–51. https://doi.org/10.1016/j.neuropharm.2014.04.016

岡村 仁. (2011). うつ病のメカニズム. バイオメカニズム学会誌, 35(1), 3–8.

奥沢 康仁. (2002). きのこを薬と副食にしたかかわりの歴史. 日本菌学会会報, 43, 105-117.

大坪 天平. (2022). 抗うつ薬を使いこなす. 女性心身医学, 27(2), 154–158.

Overmier, J. B., & Seligman, M. E. P. (1967). Effects of inescapable shock upon subsequent escape and avoidance learning. Journal of Comparative and Physiological Psychology, 63(1), 28–33. https://doi.org/10.1037/h0024166

Patted, P. G., Masareddy, R. S., Patil, A. S., Kanabargi, R. R., & Bhat, C. T. (2024). Omega-3 fatty acids: A comprehensive scientific review of their sources, functions and health benefits. Future Journal of Pharmaceutical Sciences, 10, 94. https://doi.org/10.1186/s43094-024-00667-5

Park, B. K., Kim, Y. R., Kim, Y. H., Yang, C., Seo, C. S., Jung, I. C., Jang, I. S., Kim, S. H., & Lee, M. Y. (2018). Antidepressant like effects of Gyejibokryeong hwan in a mouse model of reserpine induced depression. Biomedical Research International, 2018, 5845491. https://doi.org/10.1155/2018/5845491

Parker, V., & Morinan, A. (1986). The socially-isolated rat as a model for anxiety. Neuropharmacology, 25(6), 663–664. https://doi.org/10.1016/0028-3908(86)90224-8

Pertovaara, A. (2013). The noradrenergic pain regulation system: A potential target for pain therapy. European Journal of Pharmacology, 716(1–3), 2–7. https://doi.org/10.1016/j.ejphar.2013.01.067

Pham, T. H., Defaix, C., Xu, X., Deng, S. X., Fabresse, N., Alvarez, J. C., Landry, D. W., Brachman, R. A., Denny, C. A., & Gardier, A. M. (2018). Common Neurotransmission Recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine-Induced Sustained Antidepressant-like Effects. Biological Psychiatry, 84(1), e3–e6. https://doi.org/10.1016/j.biopsych.2017.10.020

Phillips, J. L., Norris, S., Talbot, J., Birmingham, M., Hatchard, T., Ortiz, A., Owoeye, O., Batten, L. A., & Blier, P. (2019). Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: A randomized controlled trial. American Journal of Psychiatry, 176(5), 401–409. https://doi.org/10.1176/appi.ajp.2018.18070834

Piirsalu, M., Taalberg, E., Lilleväli, K., Tian, L., Zilmer, M., & Vasar, E. (2020). Treatment with lipopolysaccharide induces distinct changes in metabolite profile and body weight in 129Sv and Bl6 mouse strains. Frontiers in Pharmacology, 11, 371. https://doi.org/10.3389/fphar.2020.00371

Pilc, A., Chaki, S., Nowak, G., & Witkin, J. M. (2008). Mood disorders: Regulation by metabotropic glutamate receptors. Biochemical Pharmacology, 75(5), 997–1006. https://doi.org/10.1016/j.bcp.2007.09.021

Planchez, B., Surget, A., & Belzung, C. (2019). Animal models of major depression: drawbacks and challenges. Journal of Neural Transmission, 126(11), 1383–1408. https://doi.org/10.1007/s00702-019-02084-y

Pogorelov, V. M., Rodriguiz, R. M., Roth, B. L., & Wetsel, W. C. (2023). The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice. Frontiers in Molecular Biosciences, 10, 1233743. https://doi.org/10.3389/fmolb.2023.1233743

Polter, A. M., & Li, X. (2010). 5-HT1A receptor-regulated signal transduction pathways in brain. Cellular Signalling, 22(10), 1406–1412. https://doi.org/10.1016/j.cellsig.2010.03.019

Potter, L. E., Zanos, P., & Gould, T. D. (2020). Antidepressant Effects and Mechanisms of Group II mGlu Receptor-Specific Negative Allosteric Modulators. Neuron, 105(1), 1-3. https://doi.org/10.1016/j.neuron.2019.12.011

Primeaux, S. D., & Holmes, P. V. (2000). Olfactory bulbectomy increases met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures. Pharmacology Biochemistry and Behavior, 67(2), 331–337. https://doi.org/10.1016/S0091-3057(00)00358-0

Raison, C. L., Capuron, L., & Miller, A. H. (2006). Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology, 27(1), 24–31. https://doi.org/10.1016/j.it.2005.11.006

Raja, S. M., Guptill, J. T., Mack, M., Peterson, M., Byard, S., Twieg, R., Jordan, L., Rich, N., Castledine, R., Bourne, S., Wilmshurst, M., Oxendine, S., Avula, S. G. C., Zuleta, H., Quigley, P., Lawson, S., McQuaker, S. J., Ahmadkhaniha, R., Appelbaum, L. G., Kowalski, K., Barksdale, C. T., Gufford, B. T., Awan, A., Sancho, A. R., Moore, M. C., Berrada, K., Cogan, G. B., DeLaRosa, J., Radcliffe, J., Pao, M., Kennedy, M., Lawrence, Q., Goldfeder, L., Amanfo, L., Zanos, P., Gilbert, J. R., Morris, P. J., Moaddel, R., Gould, T. D., Zarate, C. A. Jr., & Thomas, C. J. (2024). A Phase 1 assessment of the safety, tolerability, pharmacokinetics and pharmacodynamics of (2R,6R)-hydroxynorketamine in healthy volunteers. Clinical Pharmacology & Therapeutics, 116(5), 1314–1324. https://doi.org/10.1002/cpt.3391

Ramesh, V., Venkatesan, V., Chellathai, D., & Silamban, S. (2021). Association of serum biomarker levels and BDNF gene polymorphism with response to selective serotonin reuptake inhibitors in Indian patients with major depressive disorder. Neuropsychobiology, 80(3), 201–213. https://doi.org/10.1159/000507371

Richelson, E. (2001). Pharmacology of antidepressants. Mayo Clinic Proceedings, 76(5), 511–527. https://doi.org/10.4065/76.5.511

Riedel, G., Platt, B., & Micheau, J. (2003). Glutamate receptor function in learning and memory. Behavioural Brain Research, 140(1–2), 1–47. https://doi.org/10.1016/S0166-4328(02)00272-3

Rivero, G., Gabilondo, A. M., García Sevilla, J. A., La Harpe, R., Callado, L. F., & Meana, J. J. (2014). Increased α2 and β1 adrenoceptor densities in postmortem brain of subjects with depression: Differential effect of antidepressant treatment. Journal of Affective Disorders, 167, 343 350. https://doi.org/10.1016/j.jad.2014.06.016

Rodoshi, Z. N., Shibu, S., Omer, O., Tallal, H., Gondal, M. Z. D., Shahid, Z., Azam, A., & Abbas, N. (2025). Comparative efficacy of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in the management of post-stroke depression: A systematic review of randomized controlled trials. Cureus, 17(5), e84784. https://doi.org/10.7759/cureus.84784

Rush, A. J., & Siefert, S. E. (2009). Clinical issues in considering vagus nerve stimulation for treatment-resistant depression. Experimental Neurology, 219(1), 36–43. https://doi.org/10.1016/j.expneurol.2009.04.015

Rush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000). Vagus nerve stimulation (VNS) for treatment resistant depressions: A multicenter study. Biological Psychiatry, 47(4), 276 286. https://doi.org/10.1016/S0006-3223(99)00304-2

Salazar, A., Gonzalez-Rivera, B. L., Redus, L., Parrott, J. M., & O'Connor, J. C. (2012). Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Hormones and Behavior, 62(3), 202-209. https://doi.org/10.1016/j.yhbeh.2012.03.010

Sandler, M. (1990). Monoamine Oxidase Inhibitors in Depression: History and Mythology. Journal of Psychopharmacology, 4(3), 136-139. https://doi.org/10.1177/026988119000400307

坂本 将俊. (2017). 抗うつ剤の種類・特徴とその限界. ファルマシア, 53(7), 663-667.

Sakel, M. J. (1956) The classical Sakel shock treatment: a reappraisal. In F. Marti-Ibanez et al. (eds.) The great physiodynamic therapies in psychiatry: an historical reappraisal. New York: 13-75.

Sarchiapone, M., Carli, V., Camardese, G., Cuomo, C., Di Giuda, D., Calcagni, M. L., Focacci, C., & De Risio, S. (2006). Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Research, 147(2-3), 243–248. https://doi.org/10.1016/j.pscychresns.2006.03.001

Savić Vujović, K., Jotić, A., Medić, B., Srebro, D., Vujović, A., Žujović, J., Opanković, A., & Vučković, S. (2023). Ketamine, an Old-New Drug: Uses and Abuses. Pharmaceuticals, 17(1), 16. https://doi.org/10.3390/ph17010016

Seo, J. S., Zhong, P., Liu, A., Yan, Z., & Wang, W. (2018). Elevation of p11 in lateral habenula mediates depression-like behavior. Molecular Psychiatry, 23(5), 1113–1119. https://doi.org/10.1038/mp.2017.96

Scott, A. I. (1999). New classes of antidepressant drugs. Advances in Psychiatric Treatment, 5(2), 104 111. https://doi.org/10.1192/apt.5.2.104

Sekssaoui, M., Bockaert, J., Marin, P., Berthoux, C., Gaven, F., Cannich, A., & Chameau, P. (2024). Antidepressant-like effects of psychedelics in a chronic despair mouse model: Is the 5-HT2A receptor the unique player? Neuropsychopharmacology, 49, 747–756. https://doi.org/10.1038/s41386-024-01794-6

Seligman, M. E. P. (1972). Learned helplessness. Annual Review of Medicine, 23, 407–412. https://doi.org/10.1146/annurev.me.23.020172.002203

Seligman, M. E., & Maier, S. F. (1967). Failure to escape traumatic shock. Journal of Experimental Psychology, 74(1), 1–9. https://doi.org/10.1037/h0024514

Selikoff, I. J., Robitzek, E. H., & Ornstein, G. G. (1952). TREATMENT OF PULMONARY TUBERCULOSIS WITH HYDRAZIDE DERIVATIVES OF ISONICOTINIC ACID. JAMA, 150(10), 973–980. https://doi.org/10.1001/jama.1952.03680100015006

Sheline Y. I. (2011). Depression and the hippocampus: cause or effect?. Biological Psychiatry, 70(4), 308–309. https://doi.org/10.1016/j.biopsych.2011.06.006

Shen W. W. (1999). A history of antipsychotic drug development. Comprehensive Psychiatry, 40(6), 407–414. https://doi.org/10.1016/s0010-440x(99)90082-2

Shen, Q., Lal, R., Luellen, B. A., Earnheart, J. C., Andrews, A. M., & Luscher, B. (2010). γ-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biological Psychiatry, 68(6), 512–520. https://doi.org/10.1016/j.biopsych.2010.04.024

Shirayama, Y., & Hashimoto, K. (2018). Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: Comparison with (R)-ketamine. International Journal of Neuropsychopharmacology, 21(1), 84–88. https://doi.org/10.1093/ijnp/pyx108

Shoji, H., Maeda, Y., & Miyakawa, T. (2024). Chronic corticosterone exposure causes anxiety- and depression-related behaviors with altered gut microbial and brain metabolomic profiles in adult male C57BL/6J mice. Molecular Brain, 17(1), 79. https://doi.org/10.1186/s13041-024-01146-x

Singh, A., Bousman, C., Ng, C., Byron, K., & Berk, M. (2013). Psychomotor depressive symptoms may differentially respond to venlafaxine. International Clinical Psychopharmacology, 28. https://doi.org/10.1097/YIC.0b013e32835f1b9f

Smith, R. S. (1991). The macrophage theory of depression. Medical Hypotheses, 35(4), 298-306. https://doi.org/10.1016/0306-9877(91)90272-z

Smith, K. S., & Rudolph, U. (2012). Anxiety and depression: Mouse genetics and pharmacological approaches to the role of GABAA receptor subtypes. Neuropharmacology, 62(1), 54–62. https://doi.org/10.1016/j.neuropharm.2011.07.026

Smith, S. M., & Vale, W. W. (2006). The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues in Clinical Neuroscience, 8(4), 383–395. https://doi.org/10.31887/DCNS.2006.8.4/ssmith

Song, C., & Leonard, B. E. (2005). The olfactory bulbectomised rat as a model of depression. Neuroscience and Biobehavioral Reviews, 29(4-5), 627–647. https://doi.org/10.1016/j.neubiorev.2005.03.010

Stahl, S. M. (2021). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press. https://doi.org/10.1017/9781108975292

Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009). Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ, 339, b2880. https://doi.org/10.1136/bmj.b2880

Sturm, M., Becker, A., Schroeder, A., Bilkei-Gorzo, A., & Zimmer, A. (2015). Effect of chronic corticosterone application on depression-like behavior in C57BL/6N and C57BL/6J mice. Genes, Brain and Behavior. https://doi.org/10.1111/gbb.12208

Takaba, R., Ibi, D., Yoshida, K., Hosomi, E., Kawase, R., Kitagawa, H., Goto, H., Achiwa, M., Mizutani, K., Maeda, K., González-Maeso, J., Kitagaki, S., & Hiramatsu, M. (2024). Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(5), 3019-3035. https://doi.org/10.1007/s00210-023-02778-x

Tang, X. H., Zhang, G. F., Xu, N., Duan, G. F., Jia, M., Liu, R., Zhou, Z. Q., & Yang, J. J. (2020). Extrasynaptic CaMKIIα is involved in the antidepressant effects of ketamine by downregulating GluN2B receptors in an LPS-induced depression model. Journal of Neuroinflammation, 17(1), 181. https://doi.org/10.1186/s12974-020-01843-z

Tastan, B., Arioz, B. I., Tufekci, K. U., Tarakcioglu, E., Gonul, C. P., Genc, K., & Genc, S. (2021). Dimethyl fumarate alleviates NLRP3 inflammasome activation in microglia and sickness behavior in LPS-challenged mice. Frontiers in Immunology, 12, 737065. https://doi.org/10.3389/fimmu.2021.737065

Telega, L. M., Berti, R., Blazhenets, G., Domogalla, L.-C., Steinacker, N., Omrane, M. A., Meyer, P. T., Coenen, V. A., Eder, A.-C., & Döbrössy, M. D. (2024). Reserpine-induced rat model for depression: Behavioral, physiological and PET-based dopamine receptor availability validation. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 133, 111013. https://doi.org/10.1016/j.pnpbp.2024.111013

Tonelli, L., Holmes, A. & Postolache, T. (2008). Intranasal Immune Challenge Induces Sex-Dependent Depressive-Like Behavior and Cytokine Expression in the Brain. Neuropsychopharmacol, 33, 1038–1048. https://doi.org/10.1038/sj.npp.1301488

Trullas, R., & Skolnick, P. (1990). Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. European Journal of Pharmacology, 185(1), 1–10. https://doi.org/10.1016/0014-2999(90)90204-j

Tsankova, N., Berton, O., Renthal, W., Kumar, A., Neve, R.L., & Nestler, E.J. (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience, 9, 519–525. https://doi.org/10.1038/nn1659

Tuglu, C., Kara, S. H., Caliyurt, O., Zoroglu, S. S., & Savas, H. A. (2003). Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology, 170(4), 429–433. https://doi.org/10.1007/s00213-003-1566-z

Tullis, P. (2021). How ecstasy and psilocybin are shaking up psychiatry. Nature, 589(7834), 506-509. https://doi.org/10.1038/d41586-021-00187-9

Umbricht, D., Niggli, M., Sanwald-Ducray, P., Deptula, D., Moore, R., Grünbauer, W., Boak, L., & Fontoura, P. (2020). Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder. The Journal of Clinical Psychiatry, 81(4), 18m12470. https://doi.org/10.4088/JCP.18m12470

Vacher, C. M., Tsompanidis, A., Firestein, M. R., & Penn, A. A. (2025). Neuroactive steroid exposure impacts neurodevelopment: Comparison of human and rodent placental contribution. Journal of Neuroendocrinology, 37(7), e13489. https://doi.org/10.1111/jne.13489

Vaishnavi, S. N., Nemeroff, C. B., Plott, S. J., Rao, S. G., Kranzler, J., & Owens, M. J. (2004). Milnacipran: A comparative analysis of human monoamine uptake and transporter binding affinity. Biological Psychiatry, 55(3), 320–322. https://doi.org/10.1016/j.biopsych.2003.07.006

Valdizán, E. M., Díez-Alarcia, R., González-Maeso, J., Pilar-Cuéllar, F., García-Sevilla, J. A., Meana, J. J., & Pazos, A. (2010). α₂-Adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biological Psychiatry, 68(9), 869–872. https://doi.org/10.1016/j.biopsych.2010.07.023

Van Assche, L., Persoons, P., & Vandenbulcke, M. (2014). Neurocognitieve stoornissen in de DSM-5: een kritische bespreking [Neurocognitive disorders in DSM-5: A critical review]. Tijdschrift voor Psychiatrie, 56(3), 211–216.

Varty, G. B., Powell, S. B., Lehmann-Masten, V., Buell, M. R., & Geyer, M. A. (2006). Isolation rearing of mice induces deficits in prepulse inhibition of the startle response. Behavioural Brain Research, 169(1), 162–167. https://doi.org/10.1016/j.bbr.2005.11.025

Veroniki, A. A., Cogo, E., Rios, P., Straus, S. E., Finkelstein, Y., Kealey, R., Reynen, E., Soobiah, C., Thavorn, K., Hutton, B., Hemmelgarn, B. R., Yazdi, F., D’Souza, J., MacDonald, H., & Tricco, A. C. (2017). Comparative safety of anti epileptic drugs during pregnancy: A systematic review and network meta analysis of congenital malformations and prenatal outcomes. BMC Medicine, 15(1), 95. https://doi.org/10.1186/s12916-017-0845-1

Videbech, P., & Ravnkilde, B. (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. The American Journal of Psychiatry, 161(11), 1957–1966. https://doi.org/10.1176/appi.ajp.161.11.1957

von Rotz, R., Schindowski, E. M., Jungwirth, J., Schuldt, A., Rieser, N. M., Zahoranszky, K., Seifritz, E., Nowak, A., Nowak, P., Jäncke, L., Preller, K. H., & Vollenweider, F. X. (2023). Corrigendum to “Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.” eClinicalMedicine, 56, 101841. https://doi.org/10.1016/j.eclinm.2023.101841

Walker, A., Budac, D., Bisulco, S., Lee, A.W., Smith, R.A., Beenders, B., Kelley, K.W., & Dantzer, R. (2013). NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice. Neuropsychopharmacol, 38, 1609–1616. https://doi.org/10.1038/npp.2013.71

Wierońska, J. M., & Pilc, A. (2009). Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochemistry International, 55(1–3), 85–97. https://doi.org/10.1016/j.neuint.2009.02.019

Wilkinson, L. S., Killcross, S. S., Humby, T., Hall, F. S., Geyer, M. A., & Robbins, T. W. (1994). Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology, 10(1), 61–72. https://doi.org/10.1038/npp.1994.8

Willner, P. (1984). The validity of animal models of depression. Psychopharmacology, 83(1), 1–16. https://doi.org/10.1007/BF00427414

Willner, P. (2017). The chronic mild stress (CMS) model of depression: History, evaluation, and usage. Neurobiology of Stress, 6, 78–93. https://doi.org/10.1016/j.ynstr.2016.08.002

Witkin, J. M. (2020). mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine associated side effects. Pharmacology, Biochemistry, and Behavior, 190, 172854. https://doi.org/10.1016/j.pbb.2020.172854

Wong, E. Y. H., & Herbert, J. (2006). Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus. Neuroscience, 137(1), 83–92. https://doi.org/10.1016/j.neuroscience.2005.08.073

World Health Organization. (2022). Depression and other common mental disorders: Global health estimates.

Wright, I. K., Upton, N., & Marsden, C. A. (1991). Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze. Physiology & Behavior, 50(6), 1129–1132. https://doi.org/10.1016/0031-9384(91)90572-6

Wrynn, A. S., Mac Sweeney, C. P., Franconi, F., Lemaire, L., Pouliquen, D., Herlidou, S., Leonard, B. E., Gandon, J., & de Certaines, J. D. (2000). An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Research, 879(1-2), 193–199. https://doi.org/10.1016/s0006-8993(00)02619-6

Yadid, G., & Friedman, A. (2008). Dynamics of the dopaminergic system as a key component to the understanding of depression. Progress in Brain Research, 172, 265–286. https://doi.org/10.1016/S0079-6123(08)00913-8

Young, G. (2016). DSM-5: Basics and Critics. In: Unifying Causality and Psychology. Springer, Cham. https://doi.org/10.1007/978-3-319-24094-7_22

Zanos, P., & Gould, T. (2018). Mechanisms of ketamine action as an antidepressant. Molecular Psychiatry, 23, 801–811. https://doi.org/10.1038/mp.2017.255

Zanos, P., Highland, J. N., Stewart, B. W., Georgiou, P., Jenne, C. E., Lovett, J., Morris, P. J., Thomas, C. J., Moaddel, R., Zarate, C. A., Jr, & Gould, T. D. (2019). (2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions. Proceedings of the National Academy of Sciences of the United States of America, 116(13), 6441–6450. https://doi.org/10.1073/pnas.1819540116

Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., Dossou, K. S., Fang, Y., Huang, X. P., Mayo, C. L., Wainer, I. W., Albuquerque, E. X., Thompson, S. M., Thomas, C. J., Zarate, C. A., Jr, & Gould, T. D. (2016). NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature, 533(7604), 481–486. https://doi.org/10.1038/nature17998

Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., Jr, & Gould, T. D. (2018). Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological Reviews, 70(3), 621–660. https://doi.org/10.1124/pr.117.015198

Zhang, C., & Marek, G. J. (2008). AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32(1), 62–71. https://doi.org/10.1016/j.pnpbp.2007.07.009

Zhao, X., Zhou, Q., Zhang, H., Ono, M., Furuyama, T., Yamamoto, R., Ishikura, T., Kumai, M., Nakamura, Y., Shiga, H., & Miwa, T., & Kato, N. (2025). Olfactory deprivation promotes amyloid β deposition in a mouse model of Alzheimer’s disease. Brain Research, 1851, 149500. https://doi.org/10.1016/j.brainres.2025.149500

Zhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., & Yang, J.-J. (2014). Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. European Psychiatry, 29(7), 419–423. https://doi.org/10.1016/j.eurpsy.2013.10.005

Zueger, M., Urani, A., Chourbaji, S., Zacher, C., Roche, M., Harkin, A., & Gass, P. (2005). Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neuroscience Letters, 374(2), 142–146. https://doi.org/10.1016/j.neulet.2004.10.040